Beijing Capital Science and Technology Development Group
VC Fund
Beijing, China
Beijing Capital Science and Technology Development Group is a VC fund in Beijing focused on Medical and Biotechnology. BSTIG accelerates the reform of the scientific and technological system, promote the reform of public institutions
- Total investments:
- 19
- Last investment:
- Lead investor:
- 5%
Last updated:
For AI agents: llms.txt
Industries Beijing Capital Science and Technology Development Group invests in
Stages Beijing Capital Science and Technology Development Group invests in
Countries Beijing Capital Science and Technology Development Group invests in
Investment Focus
Industry
- Medical 5 (26%)
- Biotechnology 3 (16%)
- Biopharma 2 (11%)
- Health Care 2 (11%)
- Medical Device 2 (11%)
Stage
- Series A 3 (16%)
- Seed 2 (11%)
- Angel 2 (11%)
- Series B 1 (5%)
- Series E 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Beijing Guomai Juneng
|
Beijing Guomai Juneng is a private high-tech enterprise specializing in the research and development of commercial fusion energy. | Angel / Jun 26, 2026 | |
|
Shuowei Optoelectronics
|
Shuowei Optoelectronics focuses on next-generation photovoltaic solutions for space applications. | $14.6M / Seed / Apr 30, 2026 | |
|
Baiyi Wuyou
|
Baiyi Wuyou is a biopharmaceutical company that specializes in the research and development of vaccines and innovative drugs. The company is dedicated to studying viral protein structural biology and antibody epitopes, with a focus on understanding the mechanisms of infectious disease infection and immune responses. | Series A / Jan 01, 2026 | |
Immunochina
|
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services. | Series E / Jan 09, 2025 | |
Prime Gene Therapeutics
|
Puqi Pharmaceutical focuses on the R&D and industrialization of innovative drugs. | $41.1M / Series B / Jan 02, 2025 | |
FlightWin
|
FlightWin focuses on technology research and development, product manufacturing, and technical services of industrial-grade unmanned helicopter systems. With full R&D design, manufacturing, system integration, flight test, delivery, and after-sales service capabilities for unmanned helicopter systems, the company has a production and serviceteam. The items are frequently used in the military, military trade, emergency rescue, unmanned transportation, and other industries. | Series B / Dec 01, 2024 | |
RITS
|
RITS is an autonomous vehicle company that specializes in the development of advanced commercial vehicles and driverless technologies. | $13.9M / Series A / Mar 07, 2024 | |
Gossip Security
|
Gossip Security offers a code security analysis platform. They introduce a number of program analysis and artificial intelligence technologies to improve the analysis ability and accuracy of medium and high-risk security vulnerabilities, and become a developer-friendly code security analysis tool with low false positives. Their products andservices include shift left to develop security products, corax code security analysis platform, stork software composition analysis platform, security service system, penetration testing, source code audit, offensive and defensive drills, emergency response, devsecops system construction, security advisory, and safety training. | Seed / Jan 09, 2024 | |
Kunmai Medical
|
Beijing Kunmai Medical Technology is a medical equipment company with biological weak magnetic detection as its core technology. The company's main products are clinical class II new generation brain function imaging equipment and other biomagnetic imaging medical equipment including magnetocardiography, mainly for clinical applications inneuroscience, brain science research, neurosurgery, and psychiatric disease diagnosis. Well-known universities such as universities have established joint development and cooperative relations. | Venture - Series Unknown / Jan 01, 2024 | |
|
Megason Biotech
|
Megason Biotech is an innovative pharmaceutical supplier. | $1.9M / Angel / Jul 30, 2023 | |
| See all 19 investments → | |||
Co-Investors
Beijing E-town International Investment & Development
2 deals together
Beijing State-owned Capital Operations and Management
2 deals together
ZGC Group
2 deals together
ZGC Group
2 deals together
Baidu
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Beijing Capital Science and Technology Development Group invest in?
Beijing Capital Science and Technology Development Group invests primarily in Medical, Biotechnology and Biopharma startups, most often at Series A and Seed stage. Most of the 19 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Beijing Capital Science and Technology Development Group last invest?
The most recent investment recorded for Beijing Capital Science and Technology Development Group closed in Jun 2026. Shizune tracks 19 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
